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II. List of abbreviations 
 
AFRW alcohol-free red wine 
AI aggregation index, parameter of LORCA aggregometer 
CVD cardiovascular disease 
EI elongation index, parameter of LORCA ektacytometer 
EImax maximum of the elongation index at infinite shear stress 
HbSS hemoglobin S 
ISC irreversibly sickled cell 
LDL low-density lipoprotein 
LORCA Laser-assisted Optical Rotational Cell Analyzer 
M erythrocyte aggregation at stasis, parameter of Myrenne 
M1 erythrocyte aggregation at very low shear, parameter of Myrenne 
NO nitric-oxide 
PBS phosphate buffered saline 
PMS phenazine methosulfate 
PS physiological saline 
RBC red blood cell 
RSC reversibly sickled cell 
RW red wine 
SCD sickle cell disease 
SS shear stress 
SS1/2 shear stress required for the one-half of the maximal elongation 
γ threshold shear rate, parameter of LORCA aggregometer 
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III. Prologue 
 
1. The cardiovascular risk and the role of hemorheology 
 The Framingham Study and other epidemiological investigations have revealed 
numerous cardiovascular risk factors (e.g., genetic background, male gender, age, 
hypertension, diabetes mellitus or impaired glucose tolerance, hyperlipidemia, obesity, 
smoking and the lack of physical exercise). In contrast to the above mentioned “classic” 
factors, several studies have reported the importance of cardiovascular prevention with 
the basic principles of risk reduction (e.g., adequate lifestyle, risk screening, combined 
medicinal and operative therapies). Those examinations have described that avoidance 
of tobacco and of overweight, regular physical activity and healthy food consumption 
including Mediterranean diet with moderate red wine intake are primarily needed for the 
risk-free lifestyle of cardiovascular health [1]. In spite of these fundamental 
observations, several factors have been remained in the pathomechanism of 
cardiovascular diseases which requires deeper investigations, such as the properties of 
circulating blood. 
 Blood is a non-Newtonian suspension containing cells (e.g., erythrocytes, 
leukocytes and platelets), lipid components, proteins, carbohydrates and electrolytes. 
Blood flow is characterized by several hemorheological parameters, such as hematocrit 
(i.e., volume fraction of blood cells), plasma and whole blood viscosity (i.e., intrinsic 
resistance to flow generated by internal friction between nearby fluid layers), plasma 
proteins (e.g., fibrinogen and some globulins), erythrocyte deformability (i.e., the ability 
of red blood cells to deform in response to mechanical forces) and aggregation (i.e., 
rouleaux formation under low flow conditions). 
 Numerous investigations have presented that altered hemorheological parameters 
can impair microcirculation leading to development of various diseases [2, 3]. 
Furthermore, several literature reports have clearly shown that hemorheological 
parameters (e.g., hematocrit, plasma fibrinogen and blood viscosity) can also be 
considered as potential risk factors, and abnormalities of these parameters contribute to 
the development of cardiovascular diseases [4-6]. 
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 Other hemorheological parameters, such as red blood cell deformability and 
aggregation have also been under both basic science and clinical interest; reduced 
deformability and increased aggregation can affect the rheological behavior of blood 
and can impair in vivo tissue perfusion. 
 
2. Erythrocyte deformability 
 The form of a normal human red blood cell is a biconcave disc ~8 μm in diameter, 
~2 μm thick at the rim, and ~1 μm thick at its center [7]. These cells are extremely 
deformable as they progressively elongate under shear stress (i.e., erythrocyte 
deformability is a major determinant of high shear viscosity of blood) and form 
ellipsoids with their long axis aligned with the flow. Thus erythrocytes are capable of 
entering and transiting blood capillaries with diameters as small as ~4 μm. When the 
cells deform their surface area remains fixed; the red blood cell membrane resists area 
dilation and ruptures above 2-3% area expansion [8]. 
 There is a general agreement regarding the factors affecting erythrocyte 
deformability: cell shape and membrane surface area to volume ratio as “extrinsic” 
factors; membrane viscoelastic properties and cytosolic viscosity as “intrinsic” factors 
[9-11]. Deviations from the normal resting biconcave shape, decreased area to volume 
ratio, higher membrane shear modulus and viscosity or elevated cytoplasmic viscosity 
tend to reduce deformability [2]. 
 Erythrocyte deformability can be modified by several structural and functional 
alterations of erythrocytes generated by genetic or environmental factors. Changes in 
strictly regulated properties of blood (e.g., osmotic pressure, pH, etc), mechanical and 
oxidative damages induced by various internal or external sources (e.g., 
ischemia/reperfusion injury, mitochondrial leakage, activated leukocytes, iron overload 
caused by transfusions, etc), parasite infection (i.e., malaria caused by the genus 
Plasmodium) and genetic disorders (hemoglobinopathies, genetic modifications of red 
blood cell membrane proteins, enzyme deficiencies of erythrocyte metabolism, etc) are 
associated with decreased red blood cell deformability [2]. 
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 Abnormal red blood cell deformability is especially notable in sickle cell disease 
in which the erythrocytes become rigid at reduced oxygen levels due to intracellular 
polymerization of sickle hemoglobin leading to occlusions in microvessels and impaired 
tissue perfusion resulting in painful crisis, infarctions of various organs and increased 
resistance to flow in the lungs [12]. 
 
3. Erythrocyte aggregation 
 Erythrocyte aggregation is a major determinant of in vitro hemorheology 
occurring in either plasma or solutions with large polymers (e.g., dextran ≥ 40 kDa). 
During the process, red blood cells reversibly form linear (i.e., like stack of coins 
termed rouleaux formation) or branched aggregates. Under in vivo circumstances 
erythrocyte aggregation occurs at low shear forces thus determining especially the low 
shear viscosity of blood [13]. 
 Erythrocyte aggregation is characterized by red blood cell aggregability (i.e., the 
intrinsic cell characteristics) and the concentration of macromolecules, such as proteins 
in plasma (e.g., fibrinogen and some globulins) or neutral polymers in suspensions (e.g., 
dextran) [14-17]. 
 At these days, two parallel models explain the process of aggregation. The 
bridging theory claims that erythrocyte aggregation occurs when disaggregating forces 
are not capable to interfere the adsorption of macromolecules to the nearby cell 
surfaces, while the depletion model suggests that the decreasing protein or polymer 
concentration creates an osmotic gradient between two adjacent erythrocytes leading to 
depletion interaction [18-20]. 
 Although increased erythrocyte aggregation has been observed in various clinical 
diseases (e.g., hypertension, diabetes mellitus) [21, 22], all mechanisms of the process 
and the relations between different pathological states and red blood cell aggregation 
have not been completely understood. 
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4. Aim of the studies 
 These studies were designed to investigate the possible alterations of erythrocyte 
deformability and aggregation in two in vitro experiments: 1) effects of red wine, 
alcohol-free red wine extract and ethanol was examined; 2) light scattering results of red 
blood cells in ektacytometry were also analyzed.  
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IV. Methodology 
 
1. Early observations in hemorheology 
 First hemorheological observations were occurred in 1674 and performed by 
Anthony van Leeuwenhoek (Delft, the Netherlands), the inventor of microscope, who 
discovered the fact that erythrocytes have to deform for traversing capillaries [23] and 
also realized that red blood cells tend to form aggregates under low flow conditions 
[24]. In fact, the scientific interest appeared and turned to hemorheology just after the 
report describing the thesis of blood viscosity of Fåhraeus and Lindqvist in 1931 [25]. 
 Until these days, many investigations have been performed and numerous 
instruments have been manufactured for better understanding the structural and 
functional integrity of cellular and soluble components of blood as well as the different 
blood flow properties. 
 
2. Erythrocyte deformability measurements 
 Various approaches to the measurement of red blood cell deformability have been 
developed, such as filtration models requiring the cell to enter and pass through a small 
orifice, micropipette techniques describing deformability during a complete erythrocyte 
aspiration into a narrow glass tube, or those techniques (i.e., termed laser diffraction 
ellipsometry, also known ektacytometry) where cells are exposed to fluid shear stresses 
in defined flow fields [26-30]. 
 In these experiments, erythrocyte deformation in response to shear forces was 
determined by a LORCA ektacytometer (Laser-assisted Optical Rotational Cell 
Analyzer; R&R Mechatronics, Hoorn, Netherlands). In this instrument a dilute 
suspension of erythrocytes (~ 2 x 10
7
 cells/ml) in a viscous medium is placed in the gap 
of a Couette shearing system (i.e., created by an outer, rotating cylinder and an inner, 
static cylinder) having a laser-diode projected through the gap. 
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 The presence of red blood cells in the gap diffracts the laser light that creates a 
diffraction pattern on a diaphragm changing from circular to elliptical as cells deform 
and elongate. The pattern is captured and analyzed by a video camera and a computer 
system that calculates an elongation index (EI) as the (length - width) / (length + width) 
of the pattern for each shear stress (SS). Results are shown on an elongation index-shear 
stress (EI-SS) diagram [31] (Fig. 1A). 
 
Fig. 1: The LORCA (Laser-assisted Optical Rotational Cell Analyzer) machine and its 
two cylinders with the laser beam creating an ellipsoidal diffraction pattern on a 
diaphragm. A) Ektacytometric investigation of erythrocyte deformability with an 
elongation index-shear stress (EI-SS) diagram and the analysis of the diffraction 
pattern. B) Illustration of laser backscattering intensity vs. time curve (syllectogram) 
and the process of erythrocyte aggregation with the analysis of the diagram. This figure 
is partly based on the illustrations of the Handbook of Hemorheology and 
Hemodynamics, IOS Press, Amsterdam, pp. 250 and 256, 2007. 
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3. Erythrocyte aggregation measurements 
 In this study, red blood cell aggregation was measured with two instruments 
employing different approaches of the method of syllectometry (i.e., measuring light 
intensity changes caused by the process of erythrocyte aggregation) [32]: 1) LORCA 
aggregometer operating with laser backscattering; 2) Myrenne aggregometer using 
infrared light transmission [30]. 
 Red blood cell aggregation can be determined with a LORCA aggregometer 
detecting the laser backscattering from the aggregating blood. Erythrocytes are placed in 
the gap of the instrument and disaggregated at a high shear rate (500 s
−1
) which reduces 
rapidly to zero. Backscattering of laser light suddenly increases (i.e., sheared and 
elongated red blood cells recover their normal biconcave shape) then decreases during 
the process of aggregation (i.e., larger aggregates reflect less light than single cells) that 
is characterized by the aggregation index (AI) calculated from the areas A and B of the 
diagram (AI=A/A+B) during the first 10 seconds of the measurement [33-35] (Fig. 1B). 
Another sensitive parameter of red blood cell aggregation is called threshold shear rate 
(γ) describing the smallest shear rate which is required for the complete disaggregation 
of erythrocytes [33].  
 Erythrocyte aggregation can also be measured with a Myrenne aggregometer 
(model MA-1, Myrenne GmbH, Roetgen, Germany) that employs and measures the 
infrared light transmission through an erythrocyte suspension between a transparent 
plate and a cone. Cells are initially disaggregated by the cone at high shear (600 s
−1
) 
following which shear is abruptly stopped or reduced to 3 s
−1 
and light transmission 
integrated for 10 seconds. The instrument provides two dimensionless indices of red 
blood cell aggregation (M, aggregation at stasis; M1, at very low shear); both M and M1 
increase with enhanced aggregation (i.e., quicker process or larger aggregates let more 
light to pass through the sample) [33, 36] (Fig. 2). 
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Fig. 2: A Myrenne aggregometer MA-1 demonstrating the experimental chamber with 
the transparent plate-cone shearing system.  
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V. In vitro hemorheological effect of red wine, alcohol-free red 
wine and ethanol 
 
1. Introduction 
1.1. The “French Paradox” 
 Cardiovascular diseases (CVD) are among the most frequent causes of morbidity 
and mortality in the developed countries. Until these days, numerous risk factors (listed 
on page 4) have been determined in the pathogenesis of CVD [37-39]. 
 Several epidemiological studies have revealed that total mortality is not but CVD-
related death is substantially lower in France than in other industrialized Western-
European countries, although consumption of saturated fats and level of blood 
cholesterol are higher, while other major risk factors, such as smoking and hypertension 
are similarly prevalent in France as in other developed regions [40, 41]. 
 In contrast to the harmful pathological consequences of chronic drinking of large 
amounts of alcoholic beverages, further epidemiological studies have demonstrated a J-
shape relationship between CVD mortality and consumed alcohol amount [42-45] and 
shown that regular but moderate (i.e., not more than 10-20 g alcohol per day) red wine 
(RW) consumption results in a decreased risk of coronary heart disease [46, 47], heart 
failure [48], intermittent claudication [49] and stroke [50]. On the other hand, binge- or 
heavy alcohol drinking leads to higher mortality risk in CVD [51-53]. 
 According to other studies, wine consumption is associated with higher beneficial 
cardiovascular effects compared to other forms of alcohol; low to moderate intake of 
wine decreases the mortality risk of patients suffering from CVD, while similar amount 
of spirits drinking increases, but beer consumption does not show any influence on it 
[54, 55]. Furthermore, this beneficial protective effect depends on the type of wine; 
mortality rates in the RW drinking Mediterranean regions is lower than in Alsace, a 
white wine drinking area of France [56]. 
This chapter is based on the following scientific articles: 
- Rábai M, Tóth A, Kenyeres P, Márk L, Márton Zs, Juricskay I, Sümegi B, Tóth K. Vörösbor és alkoholmentes 
vörösborkivonat kedvező in vitro haemorheológiai hatásai. Érbetegségek 2, 45-52, 2009. 
- Rabai M, Toth A, Kenyeres P, Mark L, Marton Zs, Juricskay I, Toth K, Czopf L. In vitro hemorheological effects of 
red wine and alcohol-free red wine extract. Clin Hemorheol Microcirc 44, 227-236, 2010 
- Rabai M, Detterich JA, Wenby RB, Toth K, Meiselman HJ.   Effects of ethanol on red blood cell rheological behavior. 
Clin Hemorheol Microcirc, accepted for publication. 
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 This phenomenon (i.e., beneficial cardiovascular effects of regular and moderate 
RW consumption) has been termed the “French Paradox” [41]. 
 
1.2. Components of red wine 
 It is assumed that the favorable cardiovascular effects of RW originate in its non-
alcoholic (phenolic) and alcoholic (ethanol) components [57]. 
 Non-alcoholic component of RW contains anthocyanins and polyphenols. 
Anthocyanins, such as delphidin and malvidin are responsible for the color of wines, 
while polyphenols are believed the main source of the cardiovascular protection. 
 The most potent polyphenols of RW, such as resveratrol, katechin and quercetin 
have been extensively studied. Several researchers have demonstrated that the amount 
of polyphenols, especially the resveratrol content, depends on vintage year and variety 
[58, 59], while other authors have shown that winemaking technology and winery 
region are determinant factors as well [60-62]. Thus different RW may have different 
influence on health, as resveratrol presumably plays a role in the CVD mortality risk 
reduction. 
 Favorable cardiovascular effects of polyphenols have been widely investigated 
and their antioxidant properties are well-known [63]. In addition to the decreased 
oxidation of low-density lipoproteins (LDL) [64] and expression of LDL receptors [65], 
polyphenols induce the nitric-oxide (NO) production and reduce the platelet aggregation 
plus the production of proinflammatory eicosanoids [66, 67]. 
 Alcohol-free red wine (AFRW), an extract of RW containing phenolic 
components without ethanol, has been particularly used in animal model investigations. 
An ischemia-reperfusion rat model measurement has proven that AFRW treatment 
improves the ventricular functions and reduces the area of postinfarction remodeling 
[68]. Some other rat experiments have reported that AFRW feeding decreases the 
thrombotic tendency [69] and the degree of oxidative stress [70], while a human study 
has shown that AFRW ingestion inhibits the oxidation of LDL [71]. 
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 Several studies of RW consumption have confirmed that, in addition to the 
antioxidant phenolic components, ethanol plays a role in the beneficial cardiovascular 
effects of moderate red wine intake as well. Ethanol favorably modifies hemostasis 
leading to reduced levels of certain coagulation factors (e.g., fibrinogen, factor VII and 
von Willebrand factor) and of platelet function [72, 73]; enhanced fibrinolysis due to 
elevated levels of tissue-type plasminogen activator has also been demonstrated [73, 
74]. Alterations of plasma lipid profiles with an increase in high-density lipoprotein and 
a decrease in LDL cholesterol concentrations have been reported [75, 76]. Furthermore, 
ethanol also enhances the production of the vasodilator endothelial NO [77]. 
 
1.3. Effect of red wine and its components in hemorheology 
 Several studies have demonstrated the above mentioned inverse association 
between RW or alcohol intake and cardiovascular events, but the source of this 
cardioprotective effect is still not completely known. 
 Only a small number of in vivo and in vitro experiments have been performed to 
evaluate the effects of RW, polyphenols and ethanol on different hemorheological 
factors. Unfortunately the results are not in complete agreement. While in vitro studies 
exploring the effects of ethanol addition to blood indicate no changes of hematocrit or 
whole blood viscosity [78-80], alcohol consumption leads to dehydration without 
increased hematocrit [79, 80] but with an elevation of whole blood and plasma viscosity 
[78, 81-83]. On the other hand, several studies have demonstrated that regular but 
modest alcohol ingestion is associated with a decreased level of plasma fibrinogen [73, 
84] which was correlated with a reduction of plasma viscosity [85]. In contrast, a recent 
study has reported no changes of fibrinogen, hematocrit or blood viscosity after 
moderate RW and vodka consumption for two weeks [86]. 
 Given the current uncertainty and the lack of data regarding the specific 
hemorheological consequences, the present in vitro study was designed to further 
explore possible effects of red wine and its major components on red blood cell (RBC) 
deformability and aggregation. 
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2. Methods 
2.1. Red wine, alcohol-free red wine extract and ethanol 
 Throughout the measurements, a 2002 Merlot (Polgar Winery, Villany, Hungary) 
red wine was applied since previous chromatographic measurements have proved its 
high resveratrol content (approximately 14 mg/l), while the alcohol concentration was 
around 13% [62, 87]. For alcohol-free red wine extract measurements wine sample was 
vacuum distilled until the disappearance of alcohol. The extract was rediluted with 
distilled water, thus its osmolality became physiological plus the polyphenol and 
anthocyanin content remained similar to the original red wine [68]. Alcohol experiments 
were performed with reagent grade ethanol (Sigma-Aldrich Co., St. Louis, MO, USA), 
while physiological saline (PS) and isotonic phosphate buffered saline (PBS, 290 
mOsm/kg, pH = 7.4) were utilized as a diluent control. 
 
2.2. Blood samples 
 Venous blood samples were obtained by sterile venipuncture with a 21-gauge 
butterfly infusion set using a minimal tourniquet from 13 healthy volunteers into 
Vacutainer tubes coated with lithium heparin for the red wine and polyphenol 
measurements. For the ethanol experiment blood was taken from 7 adult laboratory 
personnel and anticoagulated with ethylenediamine-tetraacetic acid (1.5 mg/ml). Blood 
donors did not consume any ethanol-containing products within 24 hours of sampling. 
Red wine study was supported by the Regional Ethics Committee, University of Pecs, 
Pecs, Hungary, while the experiment with ethanol was approved by the Human Subjects 
Institutional Review Board, University of Southern California, Los Angeles, CA, USA. 
 
2.3. Erythrocyte deformability and aggregation testing 
 Following the RBC sample preparation (see below), erythrocyte deformability 
was studied with a LORCA ektacytometer (see page 8), while aggregation was 
measured employing a Myrenne and a LORCA aggregometers (see page 10). 
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 The viscous medium used in the RW and AFRW deformability experiments was a 
360 kDa polyvinylpyrrolidone (Sigma, 300 mOsm/kg, η=29.8 mPa·s in PBS) solution, 
while the ethanol study was performed with a 70 kDa dextran (Sigma, 297 mOsm/kg, 
η=28.4 mPa·s in PBS) solution. In both cases, the shear stress was varied, in steps, from 
0.3 to 30 Pa. Measurements were performed at 37°C. 
 For some deformability results, EI-SS data was fitted to a Lineweaver-Burke type 
non-linear equation that yields the maximum EI at infinite shear stress (EImax) and the 
stress required to achieve one-half of this maximum value (SS1/2) [88, 89]. For the more 
accurate plot fitting, negative deformability values were excluded from the analysis. 
Data fitting and analysis were carried out using non-linear regression (GraphPad Prism, 
GraphPad Software, La Jolla, CA). 
 Throughout the RBC aggregometry experiments, temperature was kept at 37°C 
for LORCA measurements, while Myrenne was operated at ambient temperature.  
 
2.4. Red blood cell suspensions 
 Red wine and blood samples were initially mixed to simulate final blood alcohol 
concentration of 0.10, 0.30 and 1%, while other samples were treated with AFRW or PS 
in a similar manner. Samples were incubated for 1 hour at ambient temperature on a 
rollerbed followed by RBC deformability and aggregation measurements. 
 In a 2
nd
 study, two general approaches were utilized to evaluate the ethanol effects 
on erythrocyte deformability: 1) direct addition of ethanol to whole blood followed by 
incubation and testing; 2) addition of ethanol only to the viscous suspending medium 
used for deformability measurements. In the direct addition studies, ethanol was added 
to whole blood to achieve final concentrations of 0, 0.25, 0.50, 1 and 2%, following 
which these samples were incubated at room temperature for 1 hour then studied. In the 
other approach, alcohol was added directly to the viscous medium used for 
ektacytometry measurements at concentrations of 0, 0.25, 0.50, 1, 2, 3, 4, 5 and 6%, 
following which untreated red blood cells were suspended in these media then 
measured. 
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 Aggregation measurements used 40% hematocrit suspensions of erythrocytes in 
autologous plasma or in a 70 kDa dextran solution (3% in PBS). In these studies, red 
blood cells were initially suspended in plasma at a 40% hematocrit, ethanol added at 
concentrations of 0, 0.25, 0.50, 1 and 2%, and incubated for 1 hour at room temperature. 
Erythrocyte-plasma samples were then tested without further processing, while cells to 
be suspended in 3% 70 kDa dextran were washed twice with PBS then re-suspended in 
the dextran at 40% hematocrit. 
 In a 3
rd
 experiment, in vitro effect of red wine, alcohol-free red wine extract and 
ethanol was examined in the presence of oxidative stress. Blood samples were 
pretreated with RW and AFRW at a concentration of 0.30% or ethanol at concentrations 
of 0, 0.25, 0.50, 1 and 2% and then the free radical generator phenazine methosulfate 
(PMS, Sigma) was added at a final concentration of 500 μM. Samples were incubated at 
37
o
C for 2 hours then erythrocyte deformability was tested. In one series, whole blood 
was treated only with PMS and alcohol added only to the viscous medium used for 
deformability measurements. 
 
2.5. Miscellaneous 
 After ethanol treatment, RBC shape was evaluated by DIC light microscopy 
(model BX50F; Olympus, Tokyo, Japan). 
 For statistical analysis paired t-tests were used to test changes from control (i.e., 
PS or PBS treated samples) with significance accepted at p<0.05.  
 The detailed technical differences in methodology between the red wine and 
ethanol studies (i.e., blood sampling, suspending medium of LORCA, etc) originate in 
the different possibilities of the two hemorheological laboratories in which the 
experiments were done. 
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3. Results 
3.1. Results of the deformability measurements 
 Our results show that no erythrocyte deformability changes were observed in any 
concentrations of the red wine and alcohol-free red wine extract treated samples 
followed by incubation then testing with LORCA (Fig. 3A). Analysis obtained using the 
Lineweaver-Burke regression indicated that in case of the two agents neither EImax, 
SS1/2 nor their ratio differed from the saline treated control (Fig. 3B, C and D). 
 
Fig. 3. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
when red wine (RW) or alcohol-free red wine extract (AFRW) (0-1%) were added to 
whole blood followed by incubation and testing with LORCA. B) EImax, C) SS1/2 and D) 
SS1/2 / EImax calculated using non-linear regression of the Lineweaver-Burke equation. 
Control (C) means physiological saline treated samples. N=13, values are mean ± SD. 
No significant differences were detected. 
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 The effects of ethanol on red blood cell deformability depended on the manner in 
which cells were exposed to the alcohol: 1) addition to whole blood followed by 
incubation caused no change in deformability (Fig. 4A); 2) addition to the LORCA 
media and testing of non-incubated cells resulted in significant, dose-dependent 
deformability increase (p<0.05) (Fig. 5A). No changes were observed in EImax, SS1/2 and 
SS1/2 / EImax for incubated cells (Fig. 4B, C and D). Conversely, EImax, SS1/2 and their 
ratio for non-incubated cells significantly decreased (p<0.05) with alcohol concentration 
of the LORCA media (Fig. 5B, C and D). Note, however, that the magnitude of these 
alcohol-induced changes differed greatly: at 6% ethanol (the highest concentration 
studied), EImax was only 1% below control whereas SS1/2 and the SS1/2 / EImax ratio 
decreased by 46% and 43%. Thus, there was essentially no meaningful change of EImax 
whereas the shear stress needed to achieve one-half of EImax was markedly reduced. 
 
Fig. 4. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
when ethanol (0-2%) was added to whole blood. B) EImax, C) SS1/2 and D) SS1/2 / EImax 
calculated using non-linear regression of the Lineweaver-Burke equation. Control (C) 
means phosphate buffered saline treated samples. N=7, values are mean ± SD. No 
significant differences were detected. 
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Fig. 5. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
when ethanol (0-6%) was added to the suspending medium of the LORCA 
ektacytometer; cells were not pre-incubated with ethanol. B) EImax, C) SS1/2 and D) SS1/2 
/ EImax calculated using non-linear regression of the Lineweaver-Burke equation. 
Control (C) means only a phosphate buffered saline dilution added to the LORCA 
media. N=7, values are mean ± SD. Stars represent significant differences from control 
samples at p<0.05, while links show differences which are not significant. 
 
3.2. Results of the oxidative stress experiment 
 The effects of RW and its major components on erythrocyte deformability when 
cells were oxidatively stressed by the free radical generator phenazine methosulfate 
were also studied using the LORCA ektacytometer. 
 As expected [90], incubation with 500 μM PMS alone caused a significant 
decrease (p<0.05) of erythrocyte deformability (Figs. 6, 7 and 8).  
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 Although AFRW pretreatment at 0.30% concentration significantly prevented 
(p<0.05) erythrocytes from the PMS generated deformability impairment, 0.30% RW 
had no such effect (Fig. 6A). The Lineweaver-Burke analysis demonstrated that EImax 
for AFRW plus PMS treated cells did not change, while SS1/2 and the SS1/2 / EImax ratio 
significantly decreased (p<0.05) by ~17% from the only PMS treated samples. On the 
other hand, EImax, SS1/2 and their ratio showed no alterations for erythrocytes treated 
with 0.30% RW and PMS compared to the only PMS damaged cells (Fig. 6B, C and D). 
 
Fig. 6. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
for whole blood incubated with 0.30% red wine (RW) or 0.30% alcohol-free red wine 
extract (AFRW) + 500 μM phenazine methosulfate (PMS); following incubation, cell 
deformability was measured with LORCA B) EImax, C) SS1/2 and D) SS1/2 / EImax 
calculated using non-linear regression of the Lineweaver-Burke equation. Control 
means physiological saline treated samples. N=7, values are mean ± SD. Stars 
represent significant differences from control, while crosses show significant 
differences from PMS treated samples at p<0.05. 
22 
 
 Changes of erythrocyte deformability again depended strongly upon the manner in 
which cells were exposed to ethanol. Red blood cells incubated for 2 hours with alcohol 
plus PMS then tested in alcohol-free LORCA media exhibited significant decreases 
(p<0.05) of deformability from PMS alone (Fig. 7A). Under these conditions, EImax for 
PMS treated cells was unaffected by the presence of ethanol during incubation, while 
both SS1/2 and the SS1/2 / EImax ratio significantly increased (p<0.05) by ~20% at 2% 
ethanol (Fig. 7B, C and D). 
 
Fig. 7. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
for whole blood incubated with ethanol (0-2%) + 500 μM phenazine methosulfate 
(PMS); following incubation the cells were tested in ethanol-free LORCA media. B) 
EImax, C) SS1/2 and D) SS1/2 / EImax calculated using non-linear regression of the 
Lineweaver-Burke equation. Control (C) means phosphate buffered saline treated 
samples. N=7, values are mean ± SD. Stars represent significant differences from 
control, while crosses show significant differences from PMS treated samples at 
p<0.05. 
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 However, PMS treated cells tested with alcohol in the LORCA media exhibited 
significant improvements (p<0.05) of deformability compared to PMS alone (Fig. 8A), 
EImax was not meaningfully altered, while SS1/2 and the SS1/2 / EImax ratio were ~17% 
lower at 2% ethanol (Fig. 8B, C and D). 
 
Fig. 8. A) Erythrocyte deformation as an elongation index (EI) versus shear stress (SS) 
for whole blood incubated with 500 μM phenazine methosulfate (PMS); following 
incubation, cell deformability was measured in LORCA media containing 0-2% ethanol. 
B) EImax, C) SS1/2 and D) SS1/2 / EImax calculated using non-linear regression of the 
Lineweaver-Burke equation. Control (C) means phosphate buffered saline treated 
samples. N=7, values are mean ± SD. Stars represent significant differences from 
control, while crosses show significant differences from PMS treated samples at 
p<0.05. 
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3.3. Results of the aggregation measurements 
 Treatments with RW and AFRW inhibited erythrocyte aggregation in a dose 
dependent manner (Fig. 9). In M and M1 mode of the Myrenne aggregometer the 
differences were significant (p<0.05) already at a concentration of 0.10%.  
 Red wine had a tendency for stronger inhibition compared to AFRW which 
became significant (p<0.05) at a concentration of 1%: mean reductions in parameter M 
and M1 at highest concentration were 48% and 22% for AFRW as well as 80% and 
43% for red wine (Fig. 9A). 
 
Fig. 9. Erythrocyte aggregation determined by A) Myrenne showing its M and M1 
parameters and B) Lorca aggregometer representing aggregation index (AI) and 
treshold shear rate (γ) after treatments with alcohol-free red wine extract (AFRW) and 
red wine (RW). Control means physiological saline treated samples. Effects of agents 
are compared within the same concentration group to eliminate the impact of sample 
dilution. N = 13, values are mean ± SD. Links represent significant difference at 
p<0.05. 
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 LORCA aggregation index (AI) confirmed these results only at the highest 
concentration where the difference between RW and AFRW became significant 
(p<0.05). Changes in LORCA threshold shear rate (γ) were concordant with Myrenne 
parameters: mean reductions in γ at the highest concentrations were 38% for AFRW and 
55% for RW (p<0.05) (Fig. 9B). 
 Further results show that erythrocyte aggregation in autologous plasma (Fig. 10A) 
or in 3% 70 kDa dextran solution (Fig. 10B) showed significant decreases (p<0.05) in a 
dose-dependent manner after ethanol treatment. The changes of the M and M1 indices 
were significant at 0.25% and above, with the greatest decreases at 1% alcohol: mean 
reductions of M and M1 parameters were 24% and 18% for aggregation in plasma and 
43% and 32% for aggregation in dextran. At 2% ethanol the aggregometer was unable 
to detect RBC aggregate formation in either medium. 
 
Fig. 10. Erythrocyte aggregation determined by Myrenne aggregometer A) in 
autologous plasma or B) in 3% 70 kDa dextran solution. No aggregation was 
measureable at 2% concentration. Control means phosphate buffered saline treated 
samples. N=7, values are mean ± SD. Links represent significant differences at p<0.05. 
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3.4. Microscopic analysis 
 Morphological analysis using DIC light microscopy demonstrated that normal 
discocytes (i.e., biconcave shaped cells) in PBS (Fig. 11A) became echinocytes (i.e., 
erythrocytes with spiky projections on the cell surface) with 2% ethanol (Fig. 11B). The 
viscous dextran medium used in the LORCA induces a slight stomatocytic (i.e., cup 
shaped red blood cells) transformation (Fig. 11C), while erythrocytes retain their 
normal, discocytic shape in dextran with 2% alcohol (Fig. 11D). 
 
Fig. 11. Morphological appearance of erythrocytes visualized by DIC light microscopy. 
A) Untreated erythrocytes in PBS demonstrating the normal, discoid shape of the cells. 
B) Echinocytes in PBS with 2% ethanol concentration. C) Stomatocytes in the viscous 
medium (dextran) of LORCA. D) Erythrocytes maintaining the normal, discocytic shape 
in dextran containing 2% ethanol. 
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4. Discussion 
 Direct addition of red wine or alcohol-free red wine extract to blood is obviously 
not physiological. Furthermore, ethanol concentrations used herein greatly exceed levels 
(over 0.50%) that are physiologically tolerable. In many locations throughout the world, 
intoxication and inability to operate machinery (e.g., drive a car) is assumed at 0.08 to 
0.1% ethanol. On the other hand, throughout the development process of a new 
pharmacological agent many different kinds of in vitro and in vivo investigations are 
made. In this in vitro study, blood was used as an isolated human tissue and the 
measurements with red wine and its major components may provide several 
reproducible pharmacodynamic effects. High, in vivo intolerable concentrations can be 
accepted in the setting of an in vitro investigation. Furthermore, measurements with 
high, intolerable alcohol concentrations can reveal valuable toxicological information. 
 In this in vitro experiment, hemorheological consequences of red wine and its 
major components were examined focusing on erythrocyte deformability measured by 
LORCA ektacytometer (see page 8) and aggregation determined by Myrenne and 
LORCA aggregometers (see page 10). 
 
4.1. Analysis of the deformability results 
 Erythrocyte deformability and its determining factors have already been discussed 
(see page 5) [2, 9-11]. The relative importance of these parameters for altering 
deformability can depend on the testing system and the level of applied forces; 
abnormal deformation behavior may be detected at low stress level forces but may not 
be evident when much higher forces are applied. In order to avoid choosing the 
appropriate stress for comparisons, we have elected to utilize a curve fitting approach 
over the entire range of shear stress (i.e., 0.3-30 Pa) in order to characterize RBC 
mechanical behavior by just two parameters (i.e., EImax and SS1/2); this approach has 
been validated and shown to be appropriate for various erythrocyte populations [88, 89]. 
 The results of our in vitro study indicate that direct addition of RW and AFRW to 
blood followed by incubation do not alter erythrocyte deformability, while ethanol can 
improve it when the cells are subjected to fluid stress in a defined shear field. 
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 These improvements were only observed when ethanol was in the viscous media 
used for ektacytometry testing (Fig. 5) and were not present when cells were incubated 
with the alcohol but tested in alcohol-free viscous media (Fig. 4). Our in vitro results 
thus indicate that the ethanol-induced deformability improvement requires the presence 
of ethanol. These results were supported by several in vivo experiments [86, 91] and in 
vitro studies suggesting that changes in the cell membrane are reversible [92, 93]. 
 Comparing our deformability results to literature reports is problematic since 
variety of methods was used. The effects of ethanol consumption depend on the 
drinking habits of the subjects tested. Using micropore filtration, studies have shown 
that erythrocyte deformability is reduced in active alcoholics [94, 95]. On the other 
hand, ektacytometry results have shown increased deformability at high shear stresses 
1.5 hours after the ethanol intake [91], while a recent study indicates no changes after 
red wine or moderate vodka consumption for two weeks [86]. Prior in vitro studies are 
also not in concordance: filterability measurements have demonstrated increased RBC 
deformability at physiological concentrations of ethanol [96], while a micropipette 
aspiration technique has shown that high, intolerable levels of ethanol decreases 
deformability [97]. Our results indicate that the greatest enhancement of deformability, 
indexed by SS1/2 and the SS1/2 / EImax ratio, was observed at 4% and 5% ethanol 
concentration, while deformability at 6% was significantly lower and similar to the 3% 
ethanol results (Fig. 5). These findings thus indicate a bi-phasic effect of ethanol: 
improved deformability followed by decreased benefits with increasing concentration. 
 As indicated above, four factors (e.g., morphology, geometry, membrane 
rheologic properties and cytoplasmic viscosity) can affect erythrocyte deformation 
behavior [9, 10]. Although ethanol can cause a discocyte-echinocyte shape change [93, 
98], cells suspended in dextran + ethanol generally have a discoidal morphology (Fig. 
11). Ingested alcohol increases plasma osmolality [99, 100], thereby reducing cell 
volume [80], increasing surface to volume ratio and elevating cytoplasmic viscosity; the 
increased ratio favors deformability, while the greater cytoplasmic viscosity has the 
opposite effect. Given that cells were always suspended in isotonic media, it thus seems 
most likely that ethanol affects the mechanical behavior of the membrane with its 
attached cytoskeleton. The importance of the cytoskeleton for the cell’s physical 
behavior has been shown in a detailed analysis of RBC membrane properties [8]. 
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 Ethanol has a polar hydroxyl group soluble in aqueous media and hence must 
distribute within the exterior glycocalyx and the interior of the cell, while the non-polar 
part of the molecule is preferentially found in the lipid bilayer [83, 101]. The fluidity of 
the lipid portion can be altered by ethanol in a dose dependent manner: 1) up to 0.3% 
there is no change in the membrane’s external layer (TMA-DPH fluorescence) or its 
hydrophobic region (DPH fluorescence) [79]; 2) increased fluidity up to 1.6% as 
assayed by electron paramagnetic resonance [101]. Note, that the less viscous lipid 
bilayer has only minimal influence on cell deformability [8, 10, 102]. Thus the 
cytoskeleton must be reversibly altered in a manner that decreases membrane shear 
modulus [103, 104]. The most likely molecular change is a weakening of spektrin-aktin 
linkages [8, 103]. In addition, it is possible that interactions between transmembrane 
proteins and cytoskeletal components are involved [10]. 
 
4.2. Analysis of the oxidative stress experiment 
 RBC deformability alterations induced by red wine, alcohol-free red wine extract 
and ethanol were also examined in the presence of oxidative stress generated by 
phenazine methosulfate. PMS is a well-known oxygen free radical generator that causes 
lipid peroxidation and structural modifications in the membrane skeletal protein 
network, leading to increased membrane rigidity and decreased deformability [90]. 
These harmful effects of PMS have successfully been employed in previous 
hemorheological studies using filtration technique where antioxidant effects of various 
cardio- and cerebrovascular drugs were investigated [105, 106]. 
 Determination of erythrocyte deformability after RW or AFRW pretreatment 
demonstrated that AFRW significantly decreased the PMS generated RBC 
deformability impairment thus prevented erythrocytes from oxidative stress (i.e., 
decreased SS1/2 and the SS1/2 / EImax ratio) (Fig. 6). Our in vitro results confirm prior in 
vivo results about the antioxidant properties of polyphenols where plasma antioxidant 
capacity was increased by the consumption of AFRW in human volunteers [107]. 
Although AFRW could partially protect erythrocytes, red wine pretreatment had no 
such preventive influence in this model. 
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 This red wine observation is presumably supported by the in vitro ethanol 
experiment, where pure ethanol + PMS were added together to whole blood followed by 
incubation then tested in alcohol-free LORCA media (Fig. 7); ethanol enhanced the 
effect of oxidative stress with increasing concentration leading to progressively 
decreased erythrocyte deformability compared to blood samples containing only PMS 
treatment (i.e., increased SS1/2 and the SS1/2 / EImax ratio). Based on these results it 
seems reasonable that the protective effect of polyphenols is attenuated by the presence 
of ethanol in the red wine portion. 
 On the other hand, the ethanol + PMS results also showed that the deformability 
of oxidatively damaged erythrocytes could be improved when ethanol was present in the 
LORCA media (Fig. 8). However, the deformability improvement was not that 
remarkable, ethanol presumably acts in a manner similar to the effects on normal 
erythrocytes (Fig. 5). Furthermore, this observed difference in the magnitude of the 
alcohol-induced deformability improvements (i.e., with vs. without PMS) confirms the 
above mentioned speculations about the modifications in the viscoelasticity of the cell 
membrane, since PMS impairs the lipid components of the membrane as well as the 
attached cytoskeletal protein network, while ethanol supposedly has the opposite effect; 
increases the fluidity of the lipid layers and alters the organization between 
transmembrane and cytoskeletal proteins. 
 
4.3. Analysis of the aggregation results 
 There are multiple factors that can characterize RBC aggregation which is 
explained by two parallel models: 1) the bridging theory; 2) the depletion layer model 
(see page 6) [18-20]. 
 In this experiment, red wine and alcohol-free red wine extract were incubated with 
whole blood then tested with Myrenne and LORCA aggregometers demonstrating a 
dose-dependent reduction in erythrocyte aggregation and indicating that RW is a more 
potent inhibitor of RBC aggregation than AFRW (Fig. 9). 
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 This decrease may be a consequence of the changes in RBC membrane and in 
plasma components especially modifications of plasma proteins. Polyphenols can bind 
to plasma proteins due to their poor water solubility. Based on the bridging theory for 
aggregation, the phenol-protein interactions presumably alter the properties of proteins 
leading to reduced capability to form cross links between cellular components leading to 
decreased erythrocyte aggregation. 
 The alcohol experiment is consistent with a prior report indicating decreased 
aggregation when ethanol is added to whole blood (Fig. 10A) [79] and also 
demonstrates that aggregation is reduced when this alcohol is added to a suspension of 
erythrocytes in 3% 70 kDa dextran (Fig. 10B). Furthermore, this experiment gave the 
explanation why RW and not AFRW showed the greater inhibitory effect on RBC 
aggregation. Decreased aggregation in plasma may be partially due to the ethanol-
induced echinocytic shape transformation (Fig. 11) [98] and to alteration or destruction 
of plasma proteins that promote aggregation (e.g., fibrinogen). Reduced RBC 
deformability also tends to reduce aggregation [20]; however, our results indicate an 
increased cellular deformability (Fig. 2). It therefore seems most likely that ethanol-
induced changes of the RBC glycocalyx are involved. Based on the depletion layer 
model for aggregation, the scale of a protein or polymer depletion zone near the 
membrane depends strongly on the ability of the macromolecule to penetrate the 
glycocalyx [19, 20]; increased penetration would reduce aggregation. 
 It is interesting to note, that this presumed change of glycocalyx properties is 
irreversible, since reduced RBC aggregation was observed for cells incubated with 
ethanol but suspended in ethanol-free dextran (Fig. 10B). 
 
5. Conclusion 
 In summary, these in vitro measurements indicate that red wine, alcohol-free red 
wine extract and ethanol have some effects on hemorheological parameters including 
erythrocyte deformability and aggregation. 
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 Our investigations proved that AFRW can protect erythrocytes and preserve their 
deformability from oxidative stress mediated impairment, while RW had no such effect 
(Fig. 6). Both RW and AFRW reduce RBC aggregation although RW is the more potent 
inhibitor (Fig. 9). Furthermore, ethanol reversibly improves erythrocyte deformability 
and irreversibly decreases RBC aggregation (Figs. 5 and 10). The presence of ethanol in 
blood enhances the oxidative stress induced RBC deformability impairment and 
improves the deformability of the previously damaged cells (Figs. 7 and 8). 
 It is important to note that the cardiovascular risk reduction associated with 
moderate red wine drinking is most likely related to the combined beneficial effects of 
red wine components (e.g., different polyphenols, ethanol): separate studies of these 
main components may not reflect the overall response seen with red wine. In our 
opinion, the found beneficial hemorheological changes (i.e., improved RBC 
deformability and decreased aggregation) enhance the tissue perfusion and may play a 
role in the cardiovascular protective effects of moderate red wine consumption. 
 Although our preliminary results demonstrate that moderate red wine 
consumption has some beneficial effects on hemorheological parameters, additional 
studies are obviously needed to prove these findings under in vivo circumstances. The 
specific molecular mechanisms involved also require further investigations. 
Identification of the most important polyphenolic components of red wine and 
investigation of their specific effect in pharmacological doses may also be interesting 
for future research.  
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VI. Analysis of light scattering by red blood cells in 
ektacytometry 
 
1. Introduction 
1.1. Deformability of sickled erythrocytes 
 As it has been mentioned before in a more-detailed description, RBC 
deformability is the ability of erythrocytes to deform in response to mechanical forces 
which is essentially required for traversing capillaries and determined by several factors 
(e.g., morphology, geometry, membrane rheologic properties and cytoplasmic viscosity) 
(see page 5) [2].  
 Pathological red blood cell deformability can be seen in several disease states 
especially in sickle cell disease (SCD) characterized as a genetic disorder due to an 
amino acid substitution (valine for glutamic acid) at the 6
th
 position in the β-globin 
chain forming hemoglobin S (HbSS). 
 At low oxygen tension HbSS starts polymerizing leading to increased intracellular 
viscosity and diminished erythrocyte deformability with the typical distorted and 
elongated cell shape (the process is also termed sickling). Blood of patient with SCD 
contains different sub-populations of erythrocytes including normal, well-deforming 
discocytes, fairly rigid sickled cells (these reversibly sickled cells (RSC) can regain the 
discoid shape at high oxygen tension) and not deformable erythrocytes (irreversibly 
sickled cells (ISC) with no ability to recover the normal shape upon oxygenation). 
 Based on the general agreement, irreversibly sickled erythrocytes can be 
recognized with microscopic analysis because their length is twice as much as their 
width (Fig. 12). These rigid cells are fragile causing continuous hemolysis and anemia. 
Furthermore, sickled cells are also responsible for other main symptoms of SCD 
including capillary occlusions, painful crisis (i.e., pain due to impaired and insufficient 
tissue perfusion), infarctions of different organs and increased blood flow resistance in 
the lungs [12, 108, 109]. 
This chapter is based on the following article: 
- Rabai M, Meiselman HJ, Wenby RB, Detterich JA, Feinberg J. Analysis of light scattering by red blood cells in 
ektacytometry using global pattern fitting. Biorheol, accepted for publication. 
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Fig.12. Different shapes of erythrocytes (i.e., normal RBC, reversibly (RSC) and 
irreversibly (ISC) distorted sickled cells) in blood obtained from a patient with sickle 
cell disease. 
 
1.2. Previous analysis of diffraction patterns 
 Various methodological approaches of red blood cell deformability have been 
developed (e.g., filtration models, micropipette aspiration techniques and 
ektacytometry) (see page 8) [26-30]. 
 The technique of ektacytometry (also known as laser diffraction ellipsometry) has 
already been described in detail (see page 8). In brief, it analyzes the laser diffraction 
patterns of red blood cells subjected to shear stress while suspended in a fluid. At low 
shear stress the essentially circular cells generate a circular diffraction pattern, while the 
increasing stress forces the cells to progressively deform into ellipsoidal shapes aligned 
with the flow, and thereby generate elliptical diffraction patterns (Fig. 13) [102, 110]. 
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Fig. 13. Contour plots of intensity diffraction patterns of a mixture of 100% normal red 
blood cells. Low shear stress (0.5 Pa): A) Observed diffraction pattern. B) Best fit of 
that diffraction pattern using a Bessel function. High shear stress (50 Pa): C) Observed 
diffraction pattern. D) Best fit of that diffraction pattern using an anomalous diffraction 
function. 
 For analyzing the laser diffraction patterns, ektacytometry takes a single level 
slice through the measured laser intensity pattern and fits the resulting contour to an 
ellipse. If the major and minor axes of the fitted ellipse have lengths “a” and “b” 
respectively, then for each shear stress an elongation index; EI = (a - b) / (a + b) can be 
assigned to the cells. 
 However, in patients with sickle cell disease, the red blood cells are a mixture of 
normal cells together with a sub-population of poorly deformable sickle cells [111]. 
With such blood, the resulting laser diffraction pattern is a weighted average of the 
diffraction pattern of rigid discs (or non-deforming cells not aligned with the flow) 
together with the normally-deforming cells [112, 113]. 
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 Under increasing shear stress, normal cells progressively deform and yield 
elliptical diffraction curves, while the poorly deformable cells exhibit rigid body 
rotation and consequently produce an essentially circular diffraction pattern. The 
combined diffraction pattern of these two kinds of cells has a cross-like appearance; it is 
a distorted ellipse with a bump or bulge at its center (Fig. 14) [114, 115]. Accordingly, 
applying the commercial ellipse-fitting routines to such patterns yields incorrect values 
for the elongation index. 
 
Fig. 14. Contour plots of intensity diffraction patterns of a mixture of 70% normal + 
30% rigid red blood cells. A) Measured diffraction pattern at high shear stress (50 Pa). 
B) Best fit to the measured diffraction pattern. C) Digital difference between the two 
patterns. Note the pronounced bumps in the center of the diffraction patterns due to the 
presence of the rigid cells. 
 Streekstra and co-workers [115] analyzed such distorted diffraction patterns by 
considering mixtures of oblate and prolate spheroids and employing the anomalous 
diffraction approximation for spheroids. They were able to theoretically generate 
diffraction patterns for various mixtures and then apply their method to deduce the 
relative concentrations of rigid and deformable human red blood cells. 
 While aiding in the understanding of such distorted patterns, their approach was 
limited to a single, high-shear stress region (60 Pa) and mixtures of discoidal plus 
maximally deformed cells, and consequently did not extract the EI values for the 
deformable cells over the wide range of stress levels used in red blood cell 
ektacytometry [116]. 
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 In this study, a new method is described to analyze the diffraction patterns 
produced by a sickle cell blood model; a mixture of normal and abnormal red blood 
cells. The method relies on global curve fitting, in which a series of diffraction patterns 
taken at different shear stresses are analyzed simultaneously using a subset of fitting 
parameters common to all of the curves. The technique can reveal the elongation index 
of the normal cells even in the presence of non-deformable cells. Additionally, the 
method can estimate the fraction of non-deformable cells present in the blood. 
 
2. Theory 
 An incident laser beam diffracts from the cell and travels to a distant screen whose 
x-y plane is perpendicular to the direction of the incident laser beam and is located at a 
distance z from the scattering cell. The intensity of the diffraction pattern observed on 
the screen is [117, 118]: 
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 is the distance from the 
red blood cell to any point (x, y, z) on the viewing screen, and k is the wavevector of the 
laser light in air. 
 The scattering function S(x, y, z) depends on the shape of the cell, and is 
calculated by first determining the amplitude of the incident light wave in a plane P' 
immediately after the cell and then propagating that transmitted wave from the plane P' 
to the plane of the viewing screen. If the light incident on the cell has a flat wavefront 
and if the screen is sufficiently far from the cell, the wave’s propagation is described by 
a Fraunhofer diffraction integral [118]. 
 The far-field diffraction pattern produced by erythrocytes depends on the shape of 
the cells, which varies with shear stress. At zero shear stress a RBC is a biconcave disc. 
It is assumed, that at low shear stress a normal RBC transforms from a biconcave disc 
into an elliptical disc having major and minor diameters a and b respectively, and 
having a uniform thickness, c (resembling a stretched hockey puck). In this case, the 
scattering function can be evaluated using Bessel function of the first kind [119]. 
Eq. 1 
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 It is assumed, that at high shear stress the red blood cell no longer resembles a 
disc of a uniform thickness and instead is modeled by an ellipsoid with axis diameters a 
> b > c. The resulting scattering function is a so-called “anomalous” diffraction pattern 
[117, 118, 120, 121]. 
 On the other hand, combinations of cells create sums of diffraction patterns. In 
general, when a laser beam passes through a sample containing both rigid and 
deformable cells, the observed laser diffraction pattern is the incoherent sum of two 
scattered light waves [122], the first from the deformable cells and the second from the 
rigid, non-deformable cells. In the present study, a least-squares fit of this composite 
calculated function was performed to the entire measured diffraction pattern. It is 
assumed, that the rigid cells remain transparent discs of fixed size for all values of shear 
stress, and so the amplitude of their diffraction pattern S(x, y, z) will be a Bessel-
function pattern. Normal cells at low to moderate shear stress (<3 Pa) are discs, but at 
high shear stress (>3 Pa) become ellipsoids. 
 
3. Global computer fits of observed diffraction patterns 
 At low values of the shear stress, both the normal and the rigid cells are described 
as discs of uniform thickness, and the fitting Bessel-function is proportional to the 
projected shadow area of the normal and of the rigid cells. In this case, there are seven 
adjustable parameters as well: 
 q1 - concentration of normal red blood cells 
 q2 - mean diameter of normal red blood cells 
 q3 - ratio of minor to major axes of normal red blood cells 
 q4 - concentration of rigid red blood cells 
 q5 - mean diameter of rigid red blood cells 
 q6 - ratio of minor to major axes of rigid red blood cells 
 q7 - uniform background of the photodetector 
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  However, since the volume of a red blood cell as well as its surface area do not 
change as the cell is stretched, the thickness of the red blood cell can be computed if the 
cell’s eccentricity and mean diameter are known; ~100 μm3 [123] and ~140 μm2 [124] 
for the fixed values of the cell’s volume and surface area were used, respectively. 
 At high values of the shear stress, the normal cells are treated as ellipsoids, while 
the rigid cells remain discs. The form of the fitting function is then a mixture of 
“anomalous” and Bessel functions, so the intensity of the light passing through the 
normal cells is determined by not only the length of minor and major axes but by the 
thickness of the cell as well, which changes with applied shear stress. However, as in 
the case of the discs, the area and the volume of the cell remain constant under shear, so 
the thickness c can be calculated from the values of the other two dimensions of the 
ellipsoid. 
 In principle, five of the above seven parameters should not vary with shear stress. 
In particular, the concentration of normal cells (q1) as well as the background counts of 
the photodetector (q7) should not vary with shear stress. Similarly, for the rigid red 
blood cells the concentration (q4), mean diameter (q5), and axes ratio (q6) should all 
stay fixed as the shear stress is varied. This condition was employed by requiring that all 
of the fitting parameters except for the mean diameter (q2) and the axes ratio (q3) of 
normal cells maintain fixed values for all shear stress, and then minimize the global 
sum of the least-squares differences for all nine shear stresses simultaneously. Thus, the 
minimized following global sum over all nine shear stresses: 
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 Only the two parameters, (q2) and (q3) are allowed to vary as the shear stress 
varies; the other five parameters are locked at their optimum values as determined by 
the computer. In effect, this method performed 23 parameter fit for all of the nine shear 
stress patterns simultaneously. Although somewhat time consuming, this approach 
yielded very well reproducible parameters. 
 
Eq. 2 
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4. Methods 
4.1. Normal and rigid blood samples 
 Venous blood samples were obtained from healthy adult subjects; the study was 
approved by the Human Subjects Institutional Review Board, University of Southern 
California, Los Angeles, CA. 
  Tourniquet was applied to locate the antecubital vein prior to venipuncture and was 
released at the start of sampling that was completed within 90 seconds; the samples 
were anticoagulated with ethylenediamine-tetraacetic acid (1.5 mg/ml). Blood samples 
were centrifuged at 1,400 x g for 5 minutes. The plasma and the white cell layer were 
removed and discarded. Erythrocytes were washed twice with phosphate buffered saline 
(PBS, 290 mOsm/kg, pH = 7.4) then re-suspended in PBS. 
 Rigid, non-deformable erythrocytes were prepared by treating with 
glutaraldehyde, a di-aldehyde that reacts quickly with amino groups. A dilute red blood 
cell/phosphate buffered saline suspension was carefully added to an equal volume of 1% 
glutaraldehyde (Sigma Chemical Co., St Louis, MO, USA) in PBS followed by gentle 
stirring for 60 minutes at room temperature. Rigid cells were washed to remove any 
unreacted glutaraldehyde, then re-suspended in phosphate buffered saline and stored at 
4°C until use. At the concentration employed the glutaraldehyde did not alter RBC 
volume or shape; light microscopy indicated that the rigid cells maintained the usual 
discoidal biconcave morphology. 
 
4.2. Mixtures of normal and rigid cells 
 Mixtures of normal and rigid erythrocytes were prepared containing 0, 5, 10, 20, 
30 and 50% rigid cells. The experimental protocol involved adjusting the normal red 
blood cell/phosphate buffered saline suspensions to a cell concentration equal to the 
rigid cell suspension using an automated hematology analyzer (Micros, Horiba-ABX, 
Irvine, CA, USA) to determine cell concentrations. Samples containing various 
proportions of rigid cells were prepared using appropriate volumes of the normal and 
rigid red blood cell suspensions while keeping the total cell concentration constant. 
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4.3. Erythrocyte deformability testing 
 The above mentioned global-fitting approach was tested with a LORCA 
ektacytometer (Laser Assisted Optical Rotational Cell Analyzer; R&R Mechatronics, 
Hoorn, Netherlands) measuring erythrocyte deformability of rigid and normal RBC 
mixtures. These different cell populations were added directly to a viscous, isotonic 70 
kDa dextran solution (Sigma, 297 mOsm/kg, η=31.4 mPa.s in PBS), and mixed well to 
obtain a uniform suspension before being measured. 
 Throughout the measurements, diffraction patterns of the deforming erythrocytes 
were captured by a video camera and digitally stored. The central region of the 
diffraction pattern also contains the undiffracted laser spot and so is very bright; it is 
physically blocked by an opaque dot affixed to the viewing screen leading to a “hole” in 
the middle of the diffraction pattern (Figs. 13 and 14). For each sample, 10 patterns 
were digitally averaged at each shear stress and used for further processing of global 
parameter fitting. 
 
5. Results and Discussion 
5.1. Diffraction patterns of normal red blood cells 
 Throughout the erythrocyte deformability measurements, nine different shear 
stresses from 0.5 Pa to 50 Pa were used for the global fit for each RBC sample, but only 
the lowest and the highest shear stresses of the laser diffraction patterns generated by 
normal erythrocytes (0% rigid cells) are shown (Fig. 13). The seven fitting parameters 
(qi) are varied to minimize simultaneously the least-square difference between the nine 
measured diffraction patterns and the calculated patterns. 
 
5.2. Diffraction patterns of a mixture of normal and rigid cells 
 Data of red blood cell samples containing 30% rigid and 70% normal erythrocytes 
are demonstrated as well (Fig. 14). 
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 Note, that at high shear stress the measured contours produced by this mixture are 
non-elliptical, however are faithfully reproduced by the calculated pattern and showed 
the computed elongation index for red blood cells at nine different values of applied 
shear stress using two different RBC samples (Fig. 15). One sample contained 
erythrocytes from normal blood, while the other contained 70% normal cells mixed with 
30% rigid cells. 
 The EI values computed using global fits are shown, as well as the EI values 
obtained using the LORCA’s elementary ellipse-fitting routine. For normal RBC 
samples the global fits and the LORCA analysis produce reassuringly identical results. 
For the normal-plus-rigid cell population the global fits still yield the correct EI values 
for the normal sub-population of cells present in the sample. Note, however, that the EI 
curve obtained using the LORCA’s ellipse fitting routine is displaced downward due to 
the presence of the rigid cells. 
 
5.3. Concentration of rigid cells in a mixture with normal cells 
 Series of blood samples were prepared and analyzed containing different fractions 
of rigid cells varying between 0 and 50%. The fitting parameters (q1) and (q4) reveal 
the concentrations of normal and rigid cells in each sample, and the ratio q4/(q1 + q4) 
yields the percentage of rigid cells in each sample. A correlation between the computed 
fraction of rigid cells determined by the global fits and the prepared fraction of rigid 
cells in that sample is found (Fig. 16). At each prepared concentration, two sets of data 
were obtained using different apertures on the LORCA’s video camera; the 
reproducibility of the computed results can be seen on the figure. 
 Although the slope of the straight-line fit is gratifyingly near unity, the intercept is 
not zero due to spillover of the un-diffracted portion of the laser beam as well as 
scattering from other objects. Such scattering is essentially the same for all shear 
stresses, and so mimics the diffraction pattern produced by the rigid cells. If necessary, 
the intercept can be brought closer to zero by excluding a larger central region of the 
intensity pattern from the least-square fit. The data here yield a low-stress diameter for 
the normal red blood cells of 8 μm, which is in agreement with the literature [7]. 
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Fig. 15. Computed Elongation Index (EI) using the LORCA’s software and using the 
techniques presented herein. Values of two blood samples are presented here: (1) 100% 
normal cells shown with unfilled (open) markers. For these cells our global fits and the 
LORCA’s ellipse-fitting routine give essentially identical EI values. (2) Mixture of 70% 
normal cells / 30% rigid cells. For the mixed cells, our global fits provide the correct EI 
of the normal cells in spite of the presence of the rigid cells. In contrast, the LORCA’s 
ellipse-fitting routine gives EI values that are markedly reduced. 
 
Fig. 16. Computed fraction of rigid cells vs. the prepared fraction of rigid cells for each 
sample. A straight line fits to the data. The intercept of the line is not zero due to 
additional scattering of laser light from sources other than the rigid cells deliberately 
added to the sample. 
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5.4. Future analysis of sickled blood 
 In sickled blood, it is expected that there is a continuous distribution in red blood 
cell deformability, while in this experiment only two cell populations (i.e., deformable 
and rigid) were used. Several studies have presented that the knowledge of cell 
deformability has clinical value. The number of circulating irreversibly sickled cells has 
been confirmed to be strongly correlated with the extent of hemolysis, but this 
correlation has not been seen in connection with the clinical severity of the disease. 
Furthermore, the number of rigid cells can provide information about the efficacy of 
therapy and may have predictive value for estimating the probability of a painful sickle 
crisis [12, 125]. 
 Nevertheless, our preliminary experiments with sickled blood show that our 
global curve-fitting technique can accurately extract the elongation index-shear stress 
behavior of the normally-deforming cells in the sample. It would be also desired if this 
technique could estimate the percentage of rigid or barely deformable sickled cells in 
the blood sample. 
 
6. Conclusion 
 Using a combination of Bessel functions and anomalous scattering functions to 
simultaneously fit ektacytometry data for multiple shear stresses can reveal the 
elongation index of erythrocytes over the entire range of shear stresses, even in the 
presence of rigid, non-deformable cells (Fig. 15). 
 In addition, this global fitting technique can yield the concentration of non-
deformable cells in the sample (Fig. 16). 
 It is thus suggested that this technique will be useful in determining the curve of 
elongation index versus shear stress of the normal cells, as well as the concentration of 
rigid cells in mixed red blood cell populations as seen, for example, in sickle cell 
disease.  
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VII. Summary of new scientific results 
 
1. Effects of red wine, alcohol-free red wine extract and ethanol 
[1] Our in vitro measurements have demonstrated that both red wine and alcohol-free 
red wine extract reduce red blood cell aggregation in plasma. Red wine showed 
stronger inhibitory effect. 
[2] Ethanol reversibly improves erythrocyte deformability and irreversibly decreases 
RBC aggregation. 
[3] Furthermore, our experiments have revealed that alcohol-free red wine extract 
protects erythrocytes and preserves their deformability from oxidative stress 
mediated impairment. 
[4] The presence of ethanol enhances the oxidative stress induced erythrocyte 
deformability impairment and improves the deformability of the previously 
damaged cells. 
 
2. Analysis of light scattering of red blood cells in ektacytometry 
[1] A new theoretical analyzer model was designed for accurately examining the 
diffraction patterns of ektacytometry technique. 
[2] It has been proven that combination of Bessel and anomalous scattering functions 
reveals the elongation index of the normally-deforming red blood cells over a 
wide range of shear stresses in the presence of non-deformable cells. 
[3] Moreover, the global curve-fitting technique yields the concentration of non-
deformable cells in the blood sample.  
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